NCT01556477 2012-03-16The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).Nordic MDS GroupPhase 2 Unknown72 enrolled
NCT00628238 2010-09-10Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia Research ConsortiumPhase 2 Unknown80 enrolled